Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Recently, original research demonstrated that the synergism between TNF- and IFN- is critical in triggering robust cell death during activating JAK/STAT1/IRF1 axis in the human monocytic cell line THP-1 and primary human umbilical vein endothelial cells (Figure 1)
Label the vial with preparation date and record the date of first puncture on the Hospira vial
The Wolverine Stack Composition & Key Research Facts Components: BPC-157 (pentadecapeptide, 15 amino acids) and TB-500 (Thymosin Beta-4 fragment) Research designation: Widely referred to as the Wolverine Stack in the pre-clinical peptide research community BPC-157 primary mechanism: VEGFR2/ERK1/2 activation, nitric oxide signalling, fibroblast migration, angiogenesis, ECM stabilisation TB-500 primary mechanism: G-actin sequestration, cytoskeletal reorganisation, keratinocyte and endothelial cell migration, stem/progenitor cell mobilisation Synergy mechanism: BPC-157 organises and vascularises tissue
In animal studies, it has shown potential in promoting wound healing, reducing inflammation, and aiding tissue regeneration
Rubino D, et al
US$ 22.16
US$ 29.28
US$ 21.33
US$ 23.41
US$ 20.24
US$ 24.16
US$ 29.78
US$ 24.25
US$ 23.00
US$ 27.27
US$ 23.08
US$ 24.31
US$ 20.07
US$ 22.84
